<span lang="EN-US">Cardiovascular diseases remain the leading cause of death, taking an estimated 17.9 million lives each year and representing 31% of all global deaths. The patient records including blood reports, cardiac echo reports, and physician’s notes can be used to perform feature analysis and to accurately classify heart disease patients. In this paper, an incremental deep learning model was developed and trained with stochastic gradient descent using feedforward neural networks. The chi-square test and the dropout regularization have been incorporated into the model to improve the generalization capabilities and the performance of the heart disease patients' classification model. The impact of the learning rate and the depth of neural networks on the performance were explored. The hyperbolic tangent, the rectifier linear unit, the Maxout, and the exponential rectifier linear unit were used as activation functions for the hidden and the output layer neurons. To avoid over-optimistic results, the performance of the proposed model was evaluated using balanced accuracy and the overall predictive value in addition to the accuracy, sensitivity, and specificity. The obtained results are promising, and the proposed model can be applied to a larger dataset and used by physicians to accurately classify heart disease patients.</span>
Abstract-Web Effort Estimation is a process of predicting the efforts and cost in terms of money, schedule and staff for any software project system. Many estimation models have been proposed over the last three decades and it is believed that it is a must for the purpose of: Budgeting, risk analysis, project planning and control, and project improvement investment analysis. In this paper, we investigate the use of Fuzzy ID3 decision tree for software cost estimation, it is designed by integrating the principles of ID3 decision tree and the fuzzy settheoretic concepts, enabling the model to handle uncertain and imprecise data when describing the software projects, which can improve greatly the accuracy of obtained estimates. MMRE and Pred are used, as measures of prediction accuracy, for this study. A series of experiments is reported using Tukutuku software projects dataset. The results are compared with those produced by three crisp versions of decision trees: ID3, C4.5 and CART.
Many cost estimation models have been proposed over the last three decades. In this study, we investigate fuzzy ID3 decision tree as a method for software effort estimation. Fuzzy ID software effort estimation model is designed by incorporating the principles of ID3 decision tree and the concepts of the fuzzy settheoretic; permitting the model to handle uncertain and imprecise data when presenting the software projects.MMRE (Mean Magnitude of Relative Error) and Pred(l) (Prediction at level l) are used, as measures of prediction accuracy, for this study. A series of experiments is reported using ISBSG software projects dataset. Fuzzy trees are grown using different fuzziness control thresholds. Results showed that optimizing the fuzzy ID3 parameters can improve greatly the accuracy of the generated software cost estimate.
Neuroimaging data may reflect the mental status of both cognitively preserved individuals and patients with neurodegenerative diseases. To find the relationship between cognitive performance and the difference between predicted and observed functional test results, we developed a Convolutional Neural Network (CNN) based regression model to estimate the level of cognitive decline from preprocessed T1-weighted MRI images. In this study, we considered the Predicted Cognitive Gap (PCG) as the biomarker to accurately classify Healthy Control (HC) subjects versus Alzheimer disease (AD) subjects. The proposed model was tested on a dataset that includes 422 HC and 377 AD cases. The performance of the proposed solution was measured using Receiver Operating Characteristic (ROC) Area Under the Curve (AUC) and achieved 0.987 (ADAS-cog), 0.978 (MMSE), 0.898 (RAVLT), 0.848 (TMT), 0.829 (DSST) for averaged brain images; and 0.985 (ADAS-cog), 0.987 (MMSE), 0.901 (RAVLT), 0.8474 (TMT), 0.796 (DSST) for middle slice skull stripped brain images. The results achieved indicate that PCG can accurately separate healthy subjects from demented ones and thus, the structure of the brain contributes to the level of human cognition and their functional abilities. Therefore, PCG could be used as a biomarker for dementia.
Digital news becomes widely accessible to a large community of users with the advancement of several channels of communication and the progression of technology and thus, contributes to the increase of spreading of fake news. The current study experiments and investigates machine learning models that classify news as either fake or real. Five classifiers were implemented using Random Forest, Support Vector Machine, Gradient Boosting, Logistic Regression, and Naïve Bayes algorithms. Models were trained using merged open-source datasets extracted from online sources covering different domains. Text lemmatization, vectorization, and tokenization were applied to extract useful information from news text and to improve the generalization capabilities and the performance of fake news classification models. The impact of the voting strategy on the performance of ensemble learning models were explored. The performance of the five classifiers was evaluated using the accuracy, the F1-Score, the recall, and the precision. The attained results are promising. The ensemble classifier trained using random forest algorithm and gradient boosting algorithm outperform the other classifiers and thus it might be used effectively against fake news spreading.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.